Vaccine production - state of the art and future needs in upstream processing

Genzel, Y.; Reichl, U.

doi:10.1007/978-1-59745-399-8_21

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

書籍の一部

Vaccine production - state of the art and future needs in upstream processing

MPS-Authors

/persons/resource/persons86303

Genzel, Y.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86448

Reichl, U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Genzel, Y., & Reichl, U. (2007). Vaccine production - state of the art and future needs in upstream processing. In R., Pörtner (Ed.), Animal Cell Biotechnology: Methods and Protocols (pp. 457-473). Totowa, New Jersey: HUMANA Press Inc.

引用: https://hdl.handle.net/11858/00-001M-0000-0013-98E9-B

要旨

The production of viral vaccines in animal cell culture can be accomplished with primary, diploid or continuous (transformed) cell lines. Each cell line, each virus type and each vaccine definition requires a specific production and purification process. Media have to be selected as well as the production vessel, production conditions and the type of process. Here, we describe different issues that have to be considered during virus production processes by discussing the influenza virus production in a microcarrier system in detail as an example. The use of serum-containing as well as serum-free media, but also the use of stirred tank bioreactors or wave bioreactors is considered. Copyright © 2008 Springer Science+Business Media, LLC. All rights reserved [accessed 2013 October 29th]